Mikostat suspension 30 ml

9.15

Product description

Product description: Nystatin oral suspension is intended for the treatment of oral and pharyngeal candidiasis in infants, children, and adults. It is used to treat gastrointestinal candidiasis (excluding esophageal) in immunocompromised patients. It can be used as an adjunct treatment for vaginal and skin candidiasis to achieve sterilization of associated intestinal candidiasis. It is recommended for prophylaxis in high-risk cases such as preterm infants, immunocompromised patients, and patients receiving chemotherapy. Usage instructions: Oral candidiasis: Infants (from 1 month to 2 years): 1 ml in the mouth 4 times daily. Children (>2 years) and adults: 1 ml in the mouth 4 times daily, preferably keeping the suspension in contact with the affected area for as long as possible. Gastrointestinal candidiasis: Infants (from 1 month to 2 years): 1 ml, 4 times daily. Children (>2 years): 1 ml, 4 times daily. Adults: 5 ml, 4 times daily. Prophylaxis: A total daily dose equivalent to one million units to reduce overgrowth of Candida in broad-spectrum antibiotic users. For prophylaxis in newborns: 1 ml once daily. General notes: The longer the suspension remains on the affected area before swallowing, the more effective it is. Treatment should continue for 48 hours after symptom improvement to prevent relapse. If symptoms persist after 14 days, re-evaluate the condition. Elderly: No specific dosage adjustments. Severe moist lesions may require the use of an alternative topical powder. Warnings and precautions: Topical nystatin preparations are not used for systemic, vaginal, or ocular infections. If irritation or allergy occurs, treatment should be stopped immediately. It is preferable to confirm the diagnosis using KOH smears or laboratory culture. Long-term studies have not demonstrated carcinogenic or mutagenic effects of nystatin. Pregnancy: Classified as category C. There are no sufficient studies on its effect on the fetus, and it is only used when necessary and under medical supervision. Breastfeeding: It is unknown if it is excreted in breast milk; use with caution. Children: Safe and effective from birth up to 16 years. Elderly: No significant differences in response have been shown, but sensitivity may be higher in some individuals. Ingredients: Nystatin. Product details: Brand: Mikostatal Type: Oral suspension

Questions you might have

‌
‌
‌‌
‌
‌
‌‌
‌
‌
‌‌
‌
‌
‌‌
‌
‌
‌‌
‌
‌
‌‌
‌